baber/WOPTO huggingface dataset:
Patent DE-69317490-T2 (DE)
Inventor: SCHEER DANIEL
IPC: B60P3/08
Filed: 1993-07-29
Granted: 1998-09-17
Abstract: The locking mechanism for a lifting device of a load-bearing platform is composed of a slideway (12) with a locking mounting plate (17) exhibiting a locking structure of the rack or friction surface type along which there moves a locking head (15) with an immobilisation runner (18), the front face of which is shaped into a complementary locking structure or into a friction surface, a mutual transverse movement between the runner and the mounting plate providing locking.   This invention is of more particular interest to the constructers of commercial vehicles with a moving deck or moving platform. <IMAGE>
Patent DE-69326759-T2 (DE)
Inventor: TEDDER THOMAS
IPC: A61P37/00
Filed: 1993-04-14
Granted: 2000-03-02
Abstract: Lymphocyte activation antigen HB15, and the human cDNA and gene sequences encoding HB15, are disclosed. HB15 is not expressed at detectable levels by circulating leukocytes but has a unique pattern of expression among tissues. HB15 is uniquely expressed by Langerhans cells within the skin and other subpopulations of dendritic cells. Also disclosed are antibodies reactive with HB15 and methods of using anti-HB15 antibodies, or other antagonists to HB15 function, to treat an immunological disorder, disease or syndrome.
Patent DE-69328650-T2 (DE)
Inventor: DENNIS STEPHEN V
IPC: G06T11/00
Filed: 1993-07-09
Granted: 2000-08-31
Abstract: A host computer and printer and method of operation is disclosed wherein the data file describing a document is examined by a resource assembler which determines which resources are required from the host computer to print the document. The resource assembler translates the document into a set of render primitives for each band or page of the document and creates an dependency list interrelating the required resources with each band or page. The resource assembler places the required resources and set of primitives into a host resource store and communicates the dependencies to other portions of the system. A resource loader uses the list to determine the most efficient manner for loading and releasing resources from a printer resource store. A resource scheduler controls the actual timing of resource and primitives transfer and determines when all required resources for a band or page are present within the printer resource store. The resource scheduler generates an execute signal which causes a resource executor to convert the primitives to a bit-map data file. The resource assembler may convert the primitives to a bit-map data file if the resource executor cannot convert the primitives in real-time while the print engine is printing the band or page. The resource assembler also converts the primitives if it is more efficient than the resource executor for converting a particular band or page. If bidirectional communication is available between the printer and host computer, the printer manages its own memory and determines the most efficient printing sequence. Enhanced error recovery is also possible with bidirectional communication. <IMAGE>
Patent DE-69333760-T2 (DE)
Inventor: OCHOA AUGUSTO C
IPC: A61K48/00
Filed: 1993-04-06
Granted: 2006-03-23
Abstract: A soluble immunosuppressive factor present in serum derived from tumor-bearing mammals, is associated with changes in TCR protein subunit levels, T lymphocyte signal transduction pathway proteins. These changes provide a method of determining the level of immunosuppression in a mammal by determining the level of expression of at least one selected TCR subunit protein, a protein in the T lymphocyte signal transduction pathway, or of the NF- kappa B/rel family and comparing the level and pattern to that found in non-immunosuppressed individuals. The method is useful to identify patients having T lymphocytes capable of activation for immunotherapy and for identifying agents which cause or reverse immunosuppression. An isolated immunosuppressive factor associated with the level of expression of the proteins is useful for suppressing the immune response, for example, in organ transplantation.
Patent DE-69410317-T2 (DE)
Inventor: PETROSKY JIMMIE T
IPC: C07C17/10
Filed: 1994-02-09
Granted: 1999-01-21
Abstract: Perchloroethylene and hydrogen chloride are made by non-catalytic thermal chlorination of hydrocarbons and/or their partially chlorinated derivatives by reacting them with chlorine in the presence of hydrogen and carbon tetrachloride as a reactive diluent, under conditions which maximize consumption of carbon tetrachloride and minimize the production of heavy ends, such as hexachlorobenzene and other tarry products. <IMAGE>
Patent DE-69412743-T2 (DE)
Inventor: UENO SADAO
IPC: A21C3/00
Filed: 1994-10-10
Granted: 1999-02-11
Abstract: The present invention provides a croissant dough-piece bending apparatus having a conveyor (3) for conveying rolled-up croissant dough pieces (1), a dough-piece bending member (81) to push the central portion of the dough piece in a downstream direction, and a pair of swingable dough-piece bending belts (9). The dough-piece (1) is pushed by the dough-piece bending member (81) toward and between the dough-piece bending-belts (9). The dough piece is correctly bent at its center by the cooperation of the bending member (81) and the bending-belts (9). By this means dough pieces can be bent without getting wrinkles on their surfaces, and symmetrically bent products of a uniform shape can be obtained. <IMAGE>
Patent DE-69420185-T2 (DE)
Inventor: GRIFFOUL THOMAS
IPC: A61F13/472
Filed: 1994-06-01
Granted: 2000-01-05
Abstract: An apparatus (1) and method for making absorbent products (17) in which a first material (10), such as absorbent fluff formed from wood pulp, is introduced into a vacuum forming chamber (12). A portion of the fluff is deposited into the cavity of a mold (19) transported through the forming chamber (12) by a forming wheel (7) so as to form a layer of pure fluff within the bottom of the mold cavity (20). A second material (11), such as superabsorbent particles or heat stabilized fibers, is introduced into the forming chamber (12) so that streams of the first (10) and second (11) materials collide within a mixing zone (24). As the mold (19) continues its travel through the forming chamber (12), a mixture of first (10) and second (11) materials from the mixing zone (24) is deposited within the mold cavity (20), thereby filling it. The portion of the mixture that extends above the surface of the mold (19) is scraped off by a scarfing brush (13,14) that directs the mixture back into the mixing zone (24), thereby creating turbulence that ensures thorough mixing of the two materials. The result is an absorbent product having a first layer formed by pure first material (10) and a second layer formed by a mixture of the first (10) and second (11) materials. <IMAGE>
Patent DE-69426334-T2 (DE)
Inventor: ANDERSSON S
IPC: A61K47/16
Filed: 1994-08-30
Granted: 2001-03-29
Abstract: Stable parenteral formulations of busulfan safe for parenteral administration are disclosed that exhibit improved bioavailability and optimize high dose busulfan therapy against malignant disease.
Patent DE-69503434-T2 (DE)
Inventor: SYLER RODNEY R
IPC: B65D39/08
Filed: 1995-04-12
Granted: 1998-11-19
Abstract: A bonding member (12) with a polymeric insert (14) is positioned inside the cylindrical wall portion (28) of a metal spud (24). Heat is applied so that the bonding member bonds to both the insert and the spud. The spud also has an internally threaded portion (26).
Patent DE-69505655-T2 (DE)
Inventor: THOMPSON MARTIN STUART
IPC: A47C27/10
Filed: 1995-05-25
Granted: 1999-07-22
Abstract: PCT No. PCT/GB95/01192 Sec. 371 Date Mar. 19, 1997 Sec. 102(e) Date Mar. 19, 1997 PCT Filed May 25, 1995 PCT Pub. No. WO95/31920 PCT Pub. Date Nov. 30, 1995A low air-loss mattress comprises a containment envelope enclosing two lengthwise extending inflatable side chambers each connected to receive air under pressure from a source and each connected to supply such air under pressure to one or more laterally extending inflatable air sacks positioned between the two side chambers. Each air sack is formed with a multiplicity of holes through which air can leave the mattress.
Patent DE-69508411-T2 (DE)
Inventor: CONNOLLY RAYMOND EDWIN
IPC: G08B13/14
Filed: 1995-09-01
Granted: 1999-09-23
Abstract: The present invention relates to a security device for fixing to a surface to allow relative movement of the device and the surface to be detected, and a connector for such a device.
Patent DE-69510077-T2 (DE)
Inventor: RUNAS MICHAEL
IPC: G11C11/401
Filed: 1995-09-29
Granted: 1999-10-28
Abstract: A memory 200 is provided which includes an array 201 of volatile memory cells 202. Addressing circuitry 205, 213 is included for providing access to selected ones of the memory cells 202. Master read/write circuitry 208 is included for reading and writing data into the selected memory cells 202. First slave circuitry 210, 211 is provided for storing data for exchange with the master read/write circuitry 208. Second slave circuitry 210/211 is also provided for storing data for exchange with the master read/write circuitry 208. Control circuitry 206, 214, 215 controls the exchanges of data between the master read/write circuitry 208 and the first and second slave circuitry 210, 211.
Patent DE-69514088-T2 (DE)
Inventor: YU JACKSON
IPC: E06B9/11
Filed: 1995-03-22
Granted: 2000-05-25
Abstract: A shutter (S) for a cabinet includes a plurality of juxtaposed slats (S1) with front and rear sides (102, 101). Each of the slats (S1) has longitudinal first and second portions (103, 104), a longitudinal intermediate portion (105) between the first and second portions (103, 104), and a pin-and-eye assembly (11) provided on the rear side (101) at the first and second portions (103, 104) for connecting pivotally adjacent ones of the slats (S1). Each of the slats (S1) further has a transparent part (1A). The intermediate portion (105) of the transparent part (1A) has a convex surface. <IMAGE>
Patent DE-69520051-T2 (DE)
Inventor: DALL OCCO TIZIANO
IPC: C08F4/60
Filed: 1995-06-19
Granted: 2001-07-19
Abstract: A process for the preparation of ethylene polymers is disclosed, comprising the polymerization reaction of ethylene in the presence of a catalyst consisting of the reaction product of:   (A) a mixture of the racemic and meso isomers of a stereorigid metallocene compound of a transition metal, belonging to Groups III, IV or V or the lanthanides in the Periodic Table of the Elements, with two cyclopentadienyl ligands connected to each other by a chemical bridge, and (B) at least one co-catalyst capable of activating both the racemic form and the meso form of the metallocene compound, selected from the alumoxanes and the compounds capable of forming an alkylmetallocene cation. In particular the process is suitable to prepare ethylene copolymers with uniform distribution of the comonomer along the polymer chain and broad molecular weight distribution.
Patent DE-69527013-T2 (DE)
Inventor: SOUPARIS HUGUES
IPC: G02B5/18
Filed: 1995-03-03
Granted: 2003-04-30
Abstract: PCT No. PCT/FR95/00255 Sec. 371 Date Feb. 15, 1996 Sec. 102(e) Date Feb. 15, 1996 PCT Filed Mar. 3, 1995 PCT Pub. No. WO95/23986 PCT Pub. Date Sep. 8, 1995Method for the production of an optically variable image including an animated element used as the model for the reproduction of a security element, by insolation of a light-sensitive material through two coherent light beams. The image is broken down into a plurality of elementary images, each corresponding to an optical effect defined by a color, the time when the image elements appear and their duration. A plurality of masks is provided, each including a number of windows defining an elementary image. Two light beams are used to light the entire substrate surface and the substrate is isolated by successively placing each mask on the substrate and in the path of the light beams. The first light beam is stationary while the second light beam is emitted from an illumination surface with adjustable dimensions and position, so as to produce a given optical effect for each elementary image.
Patent DE-69527660-T2 (DE)
Inventor: MARTIS LEO
IPC: A61K33/14
Filed: 1995-01-23
Granted: 2003-04-03
Abstract: The method relates to providing an osmotic agent for a peritoneal dialysis solution containing sodium chloride and optionally lactate, bicarbonate, calcium and magnesium ions. The osmotic agent added comprises a first composition with a weight average molecular weight of ≥ 10,000 daltons and 0.25 to 2.0 (% w/v) of a second composition with a weight average molecular weight of ≤ 300 daltons.
Patent DE-69533436-T2 (DE)
Inventor: MATHIS L
IPC: A61B17/32
Filed: 1995-01-06
Granted: 2005-09-01
Abstract: This invention is an improved method and kit for producing a desired channel or pathway in the interlamellar space in the corneal stroma for inserting a biocompatible material. The biocompatible polymer may be an intrastromal corneal ring (ICR). The method involves the use of clockwise and counter-clockwise dissectors, and optionally channel connectors and finish channel connectors. The kit contains clockwise and counter-clockwise dissectors and optionally channel connectors, finish channel connectors and probes.
Patent DE-69533813-T2 (DE)
Inventor: HAHN GARY SCOTT
IPC: A61K33/00
Filed: 1995-12-21
Granted: 2005-11-10
Abstract: Compositions and methods are provided for inhibiting skin irritation attributable to chemical irritants or environmental conditions, by the application of an anti-irritant amount of aqueous-soluble divalent strontium cation.
Patent DE-69603703-T2 (DE)
Inventor: JOURDE BERNARD
IPC: D04H18/02
Filed: 1996-01-12
Granted: 2000-04-06
Abstract: PCT No. PCT/FR96/00050 Sec. 371 Date Jul. 11, 1997 Sec. 102(e) Date Jul. 11, 1997 PCT Filed Jan. 12, 1996 PCT Pub. No. WO96/21761 PCT Pub. Date Jul. 18, 1996A brush conveyor, in particular for a velvet needle loom, includes an assembly of adjacent brushes forming a conveying plane and moving in a predetermined conveying direction. Each brush includes a body that is substantially elongated along a main axis, and each lower brush surface includes means for connecting the brush to a mechanical drive device while the upper brush surface has holes for receiving tufts of bristles. The brushes are arranged within the conveyor in such a way that their main axes are parallel to each other and lie at a predetermined angle to a transverse direction which is perpendicular to the conveying direction. The conveyor may be used in needle looms for making nonwoven articles.
Patent DE-69618670-T2 (DE)
Inventor: ERLUND HARRY
IPC: D21D5/26
Filed: 1996-10-21
Granted: 2002-08-14
Abstract: PCT No. PCT/FI96/00555 Sec. 371 Date May 26, 1998 Sec. 102(e) Date May 26, 1998 PCT Filed Oct. 21, 1996 PCT Pub. No. WO97/15717 PCT Pub. Date May 1, 1997An improved double acting deaeration vessel is most desirably used in the pulp and paper industry. The deaeration vessel removes gas from a fiber suspension without requiring fine adjustment of the final consistency of the suspension fed to the deaeration vessel. In the same gas volume where the fiber suspension is treated in the deaeration vessel a second partition wall forming a second weir is provided, and the vessel jacket is provided with one or more inlets for a second fluid medium to be introduced into the vessel, with an outlet for the substantially gas free second fluid medium. A common outlet is provided in the common gas volume for gas separated from both the fiber suspension in the second fluid medium, as well as an outlet for the fraction of the second fluid medium separated by the weir.
Patent DE-69630799-T2 (DE)
Inventor: HIRATA MITSUTERU
IPC: A61P9/00
Filed: 1996-09-04
Granted: 2004-08-12
Abstract: The present invention is directed to a pyrimidine derivative of the following formula (1) or a salt of the derivative: <CHEM> Äwherein R<1> represents a hydroxyl group, a lower alkoxy group, a phenyloxy group which may have a substituent, an aralkyloxy group which may have a substituent, or -NR<2>R<3>; X represents an oxygen atom or N-R<4>; m is 2 or 3; and n is 1 or 2 (wherein each of R<2> and R<3>, which are identical to or different from each other, represents a hydrogen atom, a hydroxyl group, a lower alkyl group which may have a substituent, a phenyl group which may have a substituent, an aralkyl group which may have a substituent, or a heterocyclic group which may have a substituent; R<4> represents a lower alkyl group, a phenyl group, a formyl group, or a lower alkoxycarbonyl group)Ü, as well as to a medicine containing the derivative or salt as the active ingredient. The compounds exhibit strong binding inhibitory activity against endothelin having potent vasoconstrictive effect. Therefore, the compounds are effective as remedies for various diseases including circulatory diseases.
Patent DE-69634004-T2 (DE)
Inventor: SUGUMI HIROYUKI
IPC: C07D471/16
Filed: 1996-05-31
Granted: 2005-11-10
Abstract: Novel fused polycyclic heterocycle derivatives having excellent antitumor effects and a process for producing the same. A compound represented by the following general formula (I) or pharmacologically acceptable salts thereof: <CHEM> wherein the ring A represents an optionally substituted monocyclic aromatic ring or a dicyclic fused ring in which at least one of the rings is an aromatic ring; the ring B represents pyrrole, 4H-1,4-oxazine, 4H-1,4-thiazine or 4(1H)-pyridone; the ring C represents an optionally substituted, monocyclic or dicyclic fused aromatic ring; and Y represents a group represented by the formula -e-f (wherein e represents a lower alkylene; and f represents amidino, guanidino or amino optionally substituted by optionally hydroxylated or optionally lower-alkylaminated lower alkyl; provided that the cases where the rings A and B are both optionally substituted monocyclic aromatic rings are excluded. Which has an excellent antitumor activity.
Patent DE-69636714-T2 (DE)
Inventor: YOKOI HARUHIKO
IPC: C07K19/00
Filed: 1996-04-26
Granted: 2007-10-18
Abstract: The present invention relates to a fusion polypeptide which comprises a polypeptide having G-CSF activity and a polypeptide having TPO activity and DNA which codes for the fusion polypeptide, to a fusion polypeptide in which a polypeptide having G-CSF activity and a polypeptide having TPO activity are fused via a spacer peptide and DNA which codes for the fusion polypeptide and to a polypeptide in which the fusion polypeptide comprising a polypeptide having G-CSF activity and a polypeptide having TPO activity is chemically modified with a polyalkylene glycol derivative. It also relates to an anemia-treating composition containing the fusion polypeptide as an active ingredient.
Patent DE-69702880-T2 (DE)
Inventor: SOUTHARD JAMES H
IPC: A61K31/335
Filed: 1997-05-06
Granted: 2001-03-01
Abstract: A composition containing taxol for the ex vivo preservation or perfusion of organs for implantation in a subject requiring such implantation, or for cardioplegia, is disclosed.
Patent DE-69703407-T2 (DE)
Inventor: AIZAWA TOSHIYUKI
IPC: C07C231/12
Filed: 1997-04-04
Granted: 2001-06-07
Abstract: A process for producing N-(1-alkoxyethyl)carboxylic amides by reacting alcohols of 1-5 carbon atoms with N-vinylcarboxylic amides in the presence of an acidic catalyst, or by utilizing unreacted starting material, unreacted intermediate or unrecovered product for synthesis of N-(1-alkoxyethyl)carboxylic amides. A process for producing N-(1-alkoxyethyl)carboxylic amides by adding a water-soluble strong acid during reaction between a carboxylic amide and a starting material containing acetaldehyde and alcohol and/or a starting material containing an acetal, in an amount of 2 x 10<-3> to 3 x 10<-1> equivalents to 1 mole of the carboxylic amide in the starting material, and using a strongly acidic ion-exchange resin as the catalyst.
Patent DE-69714865-T2 (DE)
Inventor: COOK GREGORY H
IPC: E06B9/06
Filed: 1997-06-25
Granted: 2003-05-08
Abstract: A closure system (10) includes a plurality of closure panels (17) adapted to be moved between deployed and stowed positions. All on a pair of carrier tracks (20) on opposite sides (12, 14) of a building opening. The actuator (18) in the deployed position have abutting top and bottom edges (30, 32) and parallel side surface (34) that span across the building opening. The actuators (18)  in the stowed position have abutting in inner and outer side surfaces (30, 32) in parallel top edges (30) and parallel bottom edges (32). The top and bottom edges (30, 32) maintain their top an d bottom orientation as their closure panels (17) transition between the deployed and stowed positions.
Patent DE-69716069-T2 (DE)
Inventor: LEUNBACH IB
IPC: G01R33/62
Filed: 1997-07-03
Granted: 2003-06-26
Abstract: This invention relates to a method of electron spin resonance enhanced magnetic resonance imaging which relies on ex vivo dynamic nuclear polarisation of an MR imaging agent.
Patent DE-69717294-T2 (DE)
Inventor: THOMAS ANDREW PETER
IPC: A61K/
Filed: 1997-09-23
Granted: 2003-09-04
Abstract: 4-Anilino-quinazoline derivatives of formula (I) and their salts are new. m = 1 or 2; R1 = H, OH, halo, NO2, CF3, CN, 1-3C alkyl, alkoxy, or alkylthio, or NR5R6; R2 = H, OH, halo, MeO, amino, or NO2; R3 = OH, halo, 1-3C alkyl, alkoxy, or alkanoyloxy, CF3, CN, amino, or NO2; X1 = O, CH2, S, SO, SO2, NR7CO, CONR8, SO2NR9, NR10SO2, or NR11; R5, R6 = H or 1-3C alkyl; R7-R11 = H, 1-3C alkyl, or 1-3C alkoxy(2-3C alkyl); R4 = WR12 (linked through a C atom of R12), WR13, (2-5C alkenylene)-R14, (2-5C alkynylene)-R15, W-X2-W-X3-R16, W-X4-COR22, W-X5-R27, W-X6-W-R33, R39, W-R40, W-R43, or W-R44; when X1 = O, S, SO, or SO2, then R4 can also = 1-3C alkoxy 2-4C alkyl; when X1 = O, then R4 can also = 1-4C alkyl; and provided that, when R4 = W-X2-W-X3-R16, then X1 is not CH2; W = 1-5C alkylene; X2, X3 = as X1, but not CH2; X4 = O or NR23; X5 = OCO, or as X1, but not CH2; X6 = as X1, but not CH2; R12, R14, R15 = Het; Het = 5 or 6 membered saturated heterocyclyl, containing 1 or 2 heteroatoms from O, S, N (optionally containing 1 or 2 substituents G); G = oxo, OH, halo, 1-4C alkyl, alkoxy, or hydroxyalkyl, 1-4C alkanoyl, 2-5C alkoxycarbonyl, carbamoyl, or mono- or di- (1-4C alkyl)carbamoyl; R13 = pyrrolidin-1-yl, imidazolidin-1-yl, or thiomorpholinyl (optionally containing 1 or 2 substituents G); R16 = H or 1-3C alkyl; R22 = NR24R25 or OR26; R23-R26 = as R7; R27, R33 = cyclopentyl, cyclohexyl, or Het (all optionally containing 1 or 2 substituents G), or 1-3C alkyl; provided that, when R27 = 1-3C alkyl, then X5 is a group containing S, and X1 is not CH2; R39 = pyrrolidin-3-yl, piperidin-3-yl, or piperidin-4-yl (all optionally containing 1 or 2 substituents G); R40 = piperazin-1-yl (substituted by 1 or more 1-4C alkanoyl or hydroxyalkyl, 2-5C alkoxycarbonyl, or CONR41R42); R41, R42 = H or 1-4C alkyl; R43 = morpholinyl (optionally containing 1 or 2 substituents G); and R44 = morpholinyl (substituted by at least one, and optionally 2, G); provided that when R4 = alkoxyalkyl or alkyl then R1 and/or R2 = NO2 or \- 1 R3 = 1-3C alkanoyloxy.
Patent DE-69733419-T2 (DE)
Inventor: SURMA E
IPC: C25B3/23
Filed: 1997-04-18
Granted: 2006-05-04
Abstract: The invention is a method and apparatus using high cerium concentration in the anolyte of an electrochemical cell to oxidize organic materials. The method and apparatus further use an ultrasonic mixer to enhance the oxidation rate of the organic material in the electrochemical cell.